TY - JOUR
T1 - Long-term follow-up of 124 patients with polymyositis and dermatomyositis
T2 - Statistical analysis of prognostic factors
AU - Ishizuka, Mariko
AU - Watanabe, Ryu
AU - Ishii, Tomonori
AU - Machiyama, Tomoaki
AU - Akita, Kanae
AU - Fujita, Yoko
AU - Shirota, Yuko
AU - Fujii, Hiroshi
AU - Harigae, Hideo
N1 - Publisher Copyright:
© 2015 Japan College of Rheumatology.
PY - 2016/1/2
Y1 - 2016/1/2
N2 - Objectives. The aims of this study were to clarify the long-term outcome of patients with polymyositis and dermatomyositis (PM/DM) and to elucidate prognostic factors using statistical analysis.Methods. We enrolled patients with PM/DM who visited our department between 1990 and 2014. Diagnoses of PM/DM and clinically amyopathic DM were based on the definitions of Bohan and Peter, and Sontheimer, respectively. We also obtained clinical data, such as age of onset, sex, medications, and presence of interstitial lung disease and malignancies, as well as laboratory tests, including the values of creatine kinase, KL-6, and ferritin. The follow-up was conducted until June 2014.Results. A total of 124 patients (PM: 46, DM: 78) were enrolled. The mean age of onset was 53.5 years, and females were predominant (64.5%). Overall survival rates were 93%, 86%, and 78% for 1, 5, and 10 years, respectively. The survival rates were significantly lower in patients with higher age of onset, with malignancies, and with hyperferritinemia in univariate analysis; however, multivariate analysis identified age of onset and serum ferritin as the most significant prognostic factors.Conclusions. Our study indicates that when age of onset and serum ferritin are used in combination, we can predict prognosis of patients with PM/DM.
AB - Objectives. The aims of this study were to clarify the long-term outcome of patients with polymyositis and dermatomyositis (PM/DM) and to elucidate prognostic factors using statistical analysis.Methods. We enrolled patients with PM/DM who visited our department between 1990 and 2014. Diagnoses of PM/DM and clinically amyopathic DM were based on the definitions of Bohan and Peter, and Sontheimer, respectively. We also obtained clinical data, such as age of onset, sex, medications, and presence of interstitial lung disease and malignancies, as well as laboratory tests, including the values of creatine kinase, KL-6, and ferritin. The follow-up was conducted until June 2014.Results. A total of 124 patients (PM: 46, DM: 78) were enrolled. The mean age of onset was 53.5 years, and females were predominant (64.5%). Overall survival rates were 93%, 86%, and 78% for 1, 5, and 10 years, respectively. The survival rates were significantly lower in patients with higher age of onset, with malignancies, and with hyperferritinemia in univariate analysis; however, multivariate analysis identified age of onset and serum ferritin as the most significant prognostic factors.Conclusions. Our study indicates that when age of onset and serum ferritin are used in combination, we can predict prognosis of patients with PM/DM.
KW - Dermatomyositis
UR - http://www.scopus.com/inward/record.url?scp=84952054853&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84952054853&partnerID=8YFLogxK
U2 - 10.3109/14397595.2015.1054081
DO - 10.3109/14397595.2015.1054081
M3 - Article
C2 - 26011440
AN - SCOPUS:84952054853
SN - 1439-7595
VL - 26
SP - 115
EP - 120
JO - Japanese Journal of Rheumatology
JF - Japanese Journal of Rheumatology
IS - 1
ER -